TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 79 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $166,000 | +18.6% | 123,912 | 0.0% | 0.00% | – |
| Q4 2018 | $140,000 | -71.8% | 123,912 | -31.2% | 0.00% | – |
| Q3 2018 | $496,000 | +52.6% | 180,010 | +98.0% | 0.00% | – |
| Q2 2018 | $325,000 | +16.5% | 90,924 | 0.0% | 0.00% | – |
| Q1 2018 | $279,000 | -51.3% | 90,924 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $573,000 | +10.4% | 90,924 | +19.9% | 0.00% | 0.0% |
| Q3 2017 | $519,000 | +8.4% | 75,863 | +13.0% | 0.00% | 0.0% |
| Q2 2017 | $479,000 | -31.3% | 67,136 | -11.5% | 0.00% | 0.0% |
| Q1 2017 | $697,000 | +127.8% | 75,844 | 0.0% | 0.00% | – |
| Q4 2016 | $306,000 | +26.4% | 75,844 | +20.1% | 0.00% | – |
| Q3 2016 | $242,000 | -4.3% | 63,153 | +7.2% | 0.00% | – |
| Q2 2016 | $253,000 | -49.2% | 58,899 | -45.2% | 0.00% | -100.0% |
| Q1 2016 | $498,000 | -51.3% | 107,573 | +5.5% | 0.00% | -50.0% |
| Q4 2015 | $1,022,000 | +34.5% | 101,923 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $760,000 | -72.9% | 101,923 | +72.6% | 0.00% | -60.0% |
| Q2 2015 | $2,801,000 | +82.4% | 59,036 | +40.9% | 0.01% | +66.7% |
| Q1 2015 | $1,536,000 | +6.5% | 41,910 | +15.4% | 0.00% | 0.0% |
| Q4 2014 | $1,442,000 | +134.5% | 36,319 | +17.9% | 0.00% | +200.0% |
| Q3 2014 | $615,000 | +47.8% | 30,805 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $416,000 | +104.9% | 30,805 | +65.6% | 0.00% | – |
| Q1 2014 | $203,000 | +1.5% | 18,605 | +25.8% | 0.00% | – |
| Q4 2013 | $200,000 | +19.0% | 14,795 | 0.0% | 0.00% | – |
| Q3 2013 | $168,000 | +60.0% | 14,795 | -0.6% | 0.00% | – |
| Q2 2013 | $105,000 | – | 14,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 317,900 | $11,647,000 | 4.28% |
| Opaleye Management Inc. | 175,000 | $6,412,000 | 2.98% |
| Graticule Asia Macro Advisors LLC | 413,200 | $15,139,000 | 2.02% |
| BB BIOTECH AG | 1,477,114 | $54,121,000 | 1.61% |
| Iguana Healthcare Management, LLC | 75,000 | $2,748,000 | 1.16% |
| Granite Point Capital Management, L.P. | 79,250 | $2,904,000 | 1.06% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 458,202 | $16,788,000 | 0.89% |
| Ghost Tree Capital, LLC | 130,000 | $4,764,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 605,393 | $22,182,000 | 0.84% |
| HealthCor Management, L.P. | 467,200 | $17,118,000 | 0.82% |